www.fdanews.com/articles/159831-merrimack-cancer-drug-fails-mid-stage-study-shares-fall

Merrimack Cancer Drug Fails Mid-Stage Study, Shares Fall

October 31, 2013

Merrimack’s MM-121 cancer drug failed to meet its goal in a mid-stage trial of patients with ovarian cancer.
Reuters